«Galactorrhea

Below is an extended Galactorrhea patents listing. Click here to return to the Galactorrhea main in depth entry.

Patents :
US Patent No.	Title
6471959	Human transferase
6645499	Human ena/VASP-like protein splice variant
6649737	Human galactosyltranferases
6656474	Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
6673823	Use of peroxisome proliferator activated receptor (PPAR)-.gamma. ligands as a treatment for pituitary tumors and associated conditions, such as Cushing's syndrome
6693077	Keratinocyte growth factor-2
6713060	Nek1-related protein kinase
6747018	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
6753005	Method for tissue perfusion
6784170	Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
6797819	Alkaloids
6620783	Human SMN-like protein
6613796	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
6475752	Mammalian imidazoline receptor
6492324	APJ ligand polypeptides
6500938	Composition for the detection of signaling pathway gene expression
6503896	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
6548491	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
6558935	Human transferase proteins
6566498	Human serine protease and serpin polypeptides
6569439	Process for making personal care compositions comprising titanium dioxide and personal care compositions made by the process
6589935	Insulin receptor tyrosine kinase substrate
6610526	Human E1-like protein
6800655	Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
6808895	DNA encoding oxidoreductase and polypeptide encoded thereby
6911456	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
7304161	Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
7304162	Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
7375093	Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
7378492	CD40-related receptor that binds CD40L
7384650	Skin permeation enhancement composition for transdermal hormone delivery system
7410776	Polypeptides, their production and use
7415358	Molecular toxicology modeling
7426441	Methods for determining renal toxins
7427600	Active agent delivery systems and methods for protecting and administering active agents
7429238	Systems and methods for the generation of crystalline polymorphs
7285392	Methods for identifying active compounds
7238506	Electron transport proteins
6919429	Prostate associated Ets protein
6927056	Proteases
6962799	Microtubule-associated proteins and tubulins
6989245	Screening, diagnostic and therapeutic methods relating to RIZ
7041789	RFRP-3 and DNA thereof
7060708	Active agent delivery systems and methods for protecting and administering active agents
7078427	Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
7186709	Dihydropyrancarboxamides and uses thereof
7217808	RFRP-3 and DNA thereof
7232667	Keratinocyte growth factor-2 polynucleotides
7429610	Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.